Cited by 87Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolismDementia and Cognitive Impairment Research

Anemia or low hemoglobin levels preceding Parkinson disease: A case-control study

Open access
Savica, R., Grossardt, B. R., Carlin, J. M., Icen, M., Bower, J. H., Ahlskog, J. E., Maraganore, D. M., Steensma, D. P. +1 more·2009·Neurology

Abstract

OBJECTIVE: It has been suggested that anemia may be a risk factor for dementia, for restless legs syndrome, and for Parkinson disease (PD). Thus, we investigated the association of anemia with the subsequent risk of PD using a case-control study design. METHODS: We used the medical records-linkage system of the Rochester Epidemiology Project to identify 196 subjects who developed PD in Olmsted County, Minnesota, from 1976 through 1995. Each incident case was matched by age (+/-1 year) and sex to a general population control. We reviewed the complete medical records of cases and controls in the system to detect anemia defined using the World Health Organization criteria. RESULTS: Anemia was more common in the history of cases than of controls (odds ratio 2.00, 95% confidence interval 1.31-3.06, p = 0.001). The association remained significant after adjustment for cigarette smoking, exposure to pesticides, or hysterectomy (in women). The association was not significantly different between men and women, or between PD patients with or without rest tremor. Analyses stratified by time of onset of anemia showed a greater association for anemia that started 20 to 29 years before the onset of PD. Hemoglobin levels were slightly but consistently lower in cases than in controls across all ages. CONCLUSIONS: Our results support an association between anemia experienced early in life and the later development of Parkinson disease. The interpretation of this association remains uncertain.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e3181bd80c1

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Reduced concentrations of systemic iron are associated with an increased risk of Parkinson's disease.

    “Studies have shown that reduced concentrations of systemic iron are associated with an increased risk of Parkinson’s disease.140–142”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 41 · Cited by 87

Research works printed but not linked: 2

  1. Stoltzfus RJ. Guidelines for the Use of Iron Supplements to Prevent and Treat Iron Deficiency Anemia. Washing- ton, DC: INACG/ILSI Press; 1998.
  2. Shiba M, Bower JH, Maraganore DM, et al. Anxiety disor- ders and depressive disorders preceding Parkinson's dis- ease: a case-control study. Mov Disord 2000;15:669 -677.

Authors
Savica, R., Grossardt, B. R., Carlin, J. M., Icen, M., Bower, J. H., Ahlskog, J. E., Maraganore, D. M., Steensma, D. P., & Rocca, W. A.
Affiliations
Mayo Clinic (US)
Venue
Neurology
Published
2009-10-27
Volume
73
Issue
17
Pages
1381-1387
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2046255953
Cited by
87
References
41
Citations by year
2026: 3 · 2025: 5 · 2024: 5 · 2023: 4 · 2022: 7 · 2021: 5 · 2020: 13 · 2019: 3 · 2018: 4 · 2017: 7 · 2016: 9 · 2015: 5 · 2014: 3 · 2013: 3 · 2012: 4
FWCI
2.35
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R01NS033978)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR030582)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Parkinson's disease, anemia, low hemoglobin, risk factors, Rochester Epidemiology Project, Rochester, Minnesota, restless legs syndrome, sex differences
MeSH terms
Adult, Aged, Aged, 80 and over, Anemia, Blood, Environmental Exposure, Female, Hemoglobins, Humans, Hysterectomy, Male, Medical Record Linkage, Middle Aged, Parkinson Disease, Pesticides, Smoking, Time Factors, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review